Chemistry: analytical and immunological testing – Biological cellular material tested
Patent
1982-08-10
1984-10-02
Marantz, Sidney
Chemistry: analytical and immunological testing
Biological cellular material tested
204180G, 204403, 260112R, 436 56, 436 86, 436812, G01N 3368, G01N 3350, G01N 2726
Patent
active
044748868
ABSTRACT:
Early detection of infectious mononucleosis is carried out using a sample of human blood by isolating and identifying the presence of Inmono proteins in the sample from a two-dimensional protein map with the proteins being characterized by having isoelectric banding as measured in urea of about -16 to -17 with respect to certain isoelectric point standards and molecular mass of about 70 to 75 K daltons as measured in the presence of sodium dodecylsulfate containing polyacrylamide gels, the presence of the Inmono proteins being correlated with the existence of infectious mononucleosis.
REFERENCES:
patent: 4244803 (1981-01-01), Aladjem
patent: 4301142 (1981-11-01), Enders
patent: 4322274 (1982-03-01), Wilson
MacKinney, Jr., Archie A., Blood, vol. 32(2), 217-224 (1968).
Willard, Karen E., Clin. Chem., vol. 28(4), 1031-1035 (1982).
Edwards, Jesse J. et al., Clin. Chem., vol. 28(1), 160-163 (1982).
Esposito Michael F.
Lohff William
Marantz Sidney
The United States of America as represented by the United States
Weinberger James W.
LandOfFree
Method for early detection of infectious mononucleosis by identi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for early detection of infectious mononucleosis by identi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for early detection of infectious mononucleosis by identi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-527136